New therapy options for chronic immune thrombocytopenic purpura: a breath of fresh air. Introduction.
Francesco
Rodeghiero
R
Hematology Department, San Bortolo Hospital, I-36100 Vicenza, Italy. francesco.rodeghiero@hemato.ven.it
D001565:Benzoates / Q000627:therapeutic use; D002908:Chronic Disease; D016503:Drug Delivery Systems / Q000639:trends; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000188:drug therapy*; D011720:Pyrazoles / Q000627:therapeutic use; D011961:Receptors, Fc / Q000627:therapeutic use; D053628:Receptors, Thrombopoietin / Q000819:agonists*; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use; D013926:Thrombopoietin / Q000627:therapeutic use
D001565:Benzoates; D006834:Hydrazines; D011720:Pyrazoles; D011961:Receptors, Fc; D053628:Receptors, Thrombopoietin; D011993:Recombinant Fusion Proteins; C082218:MPL protein, human; D013926:Thrombopoietin; C488777:romiplostim; C520809:eltrombopag